Paxlovid

Indicated For

COVID-19

About This Medication

# US Government Patient Assistance Program (USG PAP) Patient Guide: How to Get Paxlovid at Low or No Cost Paxlovid (nirmatrelvir with ritonavir) is an oral antiviral medication used to treat mild-to-moderate COVID-19 in adults and certain pediatric patients at high risk for progression to severe disease. This guide explains the **US Government Patient Assistance Program (USG PAP)**, operated by Pfizer, which provides **Paxlovid for free** to eligible government-insured or uninsured patients through December 31, 2026. ## About Paxlovid **Paxlovid** combines two tablets: nirmatrelvir, which stops the virus from replicating, and ritonavir, which helps the body process nirmatrelvir effectively. It's typically taken for 5 days (30 tablets total) and must start within 5 days of COVID-19 symptoms. Your doctor prescribes it if you're at high risk, such as being 50+, unvaccinated, or having conditions like diabetes, heart disease, or obesity. It's not for everyone—discuss risks like drug interactions with your healthcare provider.[1][2] ## Who Qualifies for USG PAP? The program targets patients who **cannot use commercial insurance**. Eligible groups include: - **Medicare** (Part D or without prescription coverage, especially if copays are unaffordable) - **Medicaid** - **TRICARE** - **VA Community Care Network** - **Uninsured** patients **Commercial insurance patients** are **not eligible**—they may use the separate PAXCESS Co-Pay Savings Program instead.[1][9] Starting March 1, 2025, **income verification** is required for some Medicare patients with high copays or no coverage. Eligibility ties to **300% of the Federal Poverty Level (FPL)**. For 2025 guidelines: | Household Size | Annual Income Limit (300% FPL) | |----------------|-------------------------------| | 1 person | $46,950 | | 2 people | $63,450 | | 3 people | $79,950 | | 4 people | $96,450 | *Add ~$16,500 per additional person. These are approximate; confirm current FPL at enrollment. Government-insured patients may qualify regardless of income in some cases.*[10][4] **Notes**: U.S. residents (including Puerto Rico), 18+ years old. Program offered via U.S. Department of Health and Human Services partnership—not directly owned by Pfizer. Free access ends December 31, 2026.[1][9] ## Insurance Requirements - **Eligible**: Medicare, Medicaid, TRICARE, VA, or uninsured. - **Not Eligible**: Commercial/private insurance (use PAXCESS Co-Pay card).[1][2][9] Under-insured Medicare patients with high copays due to low income now qualify with proof. Check your plan first—some cover Paxlovid fully.[4][10] ## Step-by-Step Application Process Enrollment is **quick and flexible**—about **5 minutes online** or by phone. Patients, caregivers, doctors, or pharmacists can apply.[3][6] 1. **Get Your Prescription**: Ask your doctor for Paxlovid. 2. **Enroll**: - **Online**: Visit [paxlovid.iassist.com](https://paxlovid.iassist.com) or PAXCESS Patient Portal. Enter name, DOB, address, insurance type (Medicare/Medicaid/uninsured), and prescription details.[3][7] - **Phone**: Call **(877) 219-7225** (Mon-Fri 9AM-9PM ET, Sat-Sun 9AM-5PM ET). Multilingual support available.[1][2] 3. **Submit Documents** (if requested, especially for income verification post-2025): - Proof of income (tax return, pay stubs, SSI/SSDI letter) - Proof of residency (utility bill, ID) - Prescription copy[Provided Data] 4. **Receive Voucher**: Generated in real-time. Print or show digitally at pharmacy.[3][7] 5. **Fill at Pharmacy**: Use voucher for free pickup. Find participating locations via phone line.[2] No activation needed for digital vouchers.[9] ## Timeline and Delivery - **Enrollment**: Instant voucher upon approval (5 minutes typical).[3][6] - **Processing**: Real-time for most; income checks may add 1-2 days. - **Delivery**: - **Local pharmacy** (preferred—many participate).[2] - **Overnight mail order** if needed (arrange via hotline).[2][Provided Data] Start treatment ASAP—Paxlovid works best early. Program valid through 2026.[1] ## Alternatives if Denied or Ineligible - **Commercial Insurance**: PAXCESS Co-Pay card—pays as little as $0 (up to $1,000 savings).[1][5] - **Other Assistance**: Check state programs, NeedyMeds.org, or RxAssist.org. - **Rebate Programs**: Some Medicare plans offer 100% rebates.[4] - **Generic/Other Treatments**: No biosimilars yet. Alternatives like molnupiravir (Lagevrio) via similar programs—ask your doctor.[Provided Data] If denied, call hotline for appeal or other options.[6] ## Important Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility, income thresholds, and terms can change—**always verify directly** with (877) 219-7225 or paxlovid.iassist.com. Not medical advice; consult your doctor. Pfizer and USG PAP not liable for misuse. Free access ends 12/31/2026—plan ahead.[1][2][9] *Word count: ~950*

Program information last verified: March 30, 2026